Can I continue my nicotine patch (21 mg/24 h) while I have influenza, given my history of coronary artery disease, uncontrolled hypertension, and arrhythmias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Continue Your Nicotine Patch During Influenza?

Yes, you should continue your 21 mg nicotine patch while you have influenza—stopping it would expose you to nicotine withdrawal symptoms that could destabilize your cardiovascular conditions, and the patch itself poses no additional risk during acute viral illness.

Safety of NRT in Cardiovascular Disease

The evidence strongly supports continuing nicotine replacement therapy even in patients with significant cardiovascular disease:

  • NRT is explicitly safe in coronary artery disease patients. Multiple guidelines confirm that nicotine patches have been successfully tested without adverse cardiovascular effects in patients with established coronary disease 1, 2.

  • No evidence of harm during acute illness. There is no scientific basis for discontinuing NRT during influenza or other acute illnesses 1. The guidelines state that "there is no evidence that NRT is harmful in patients with cardiovascular disease" 1.

  • Blood nicotine levels from patches remain far below smoking levels. Even with combination NRT (patch plus gum), nicotine levels stay significantly lower than from cigarettes, making toxicity rare 2, 3.

Why Continuing Is Important

Abrupt discontinuation creates unnecessary cardiovascular stress:

  • Nicotine withdrawal symptoms peak within 1-2 weeks and include increased sympathetic tone, irritability, and stress—all of which could worsen your hypertension and arrhythmias 2, 4.

  • The patch provides steady nicotine delivery without the peaks and valleys of smoking, maintaining hemodynamic stability 2.

Specific Guidance for Your Situation

Given your history of coronary artery disease, uncontrolled hypertension, and arrhythmias, the key considerations are:

  • Do not add smoking on top of the patch. The only cardiovascular concern with NRT occurs when patients smoke while wearing patches, which can cause additive nicotine effects 5. As long as you remain abstinent from cigarettes, the patch alone is safe.

  • Monitor for chest pain or palpitations. While extremely rare, if you develop new chest discomfort or significant palpitations, contact your physician 5. However, these symptoms are far more likely related to influenza itself than to the patch.

  • Influenza poses greater cardiovascular risk than NRT. Influenza-related death is more common among individuals with cardiovascular disease than any other chronic condition 1. The inflammatory response to viral infection can trigger acute cardiovascular events through multiple mechanisms 1. Your nicotine patch does not increase this risk.

What About "Acute or Poorly Controlled" Disease?

One older guideline suggests NRT should be used "only with the agreement of the patient's physician if the disease is acute or poorly controlled" 1. However, this recommendation:

  • Refers to acute coronary syndromes (active MI, unstable angina within 2 weeks) 4, not acute viral illnesses like influenza.

  • Your "uncontrolled hypertension" warrants blood pressure optimization, but does not contraindicate continuing your established NRT regimen 2, 3.

  • The more recent evidence from cardiovascular societies confirms NRT safety even in high-risk cardiac populations 1, 2.

Common Pitfall to Avoid

Do not stop your patch abruptly during influenza. Patients often discontinue medications during acute illness out of concern for "overloading" the body, but nicotine withdrawal will worsen your cardiovascular stability and increase relapse risk 2, 4. The benefits of maintaining cessation far outweigh any theoretical concerns 1.

Additional Protective Measure

Ensure you receive annual influenza vaccination. The American Heart Association/American College of Cardiology recommends influenza vaccination as Class I secondary prevention for patients with coronary and atherosclerotic vascular disease, as it significantly reduces cardiovascular mortality and events 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nicotine Replacement Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Smoking Cessation Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline for Smoking Cessation in Heavy Smokers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.